This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Dr. Leana Wen, a health news commentator for The Washington Post and CNN, is known…
Very early this morning the U.S. House passed a bill that would result in more…
Originally broadcast May 15, 2025 Millions are still living with the effects of Long COVID…
Originally broadcast May 8, 2025 Skin cancer is the most common cancer in the United…
A recent survey surprisingly found only 41% of physicians were “very confident” about their ability…
Originally broadcast April 22, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. announced…